HK1200326A1 - Rotavirus subunit vaccines and methods of making and use thereof - Google Patents

Rotavirus subunit vaccines and methods of making and use thereof

Info

Publication number
HK1200326A1
HK1200326A1 HK15100745.1A HK15100745A HK1200326A1 HK 1200326 A1 HK1200326 A1 HK 1200326A1 HK 15100745 A HK15100745 A HK 15100745A HK 1200326 A1 HK1200326 A1 HK 1200326A1
Authority
HK
Hong Kong
Prior art keywords
making
methods
subunit vaccines
rotavirus subunit
rotavirus
Prior art date
Application number
HK15100745.1A
Other languages
English (en)
Chinese (zh)
Inventor
Russell F Bey
Randy R Simonson
Kamesh Reddy Sirigireddy
Benjamin Matthew Hause
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of HK1200326A1 publication Critical patent/HK1200326A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
HK15100745.1A 2012-02-14 2015-01-23 Rotavirus subunit vaccines and methods of making and use thereof HK1200326A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261598624P 2012-02-14 2012-02-14
PCT/US2013/026179 WO2013123219A1 (en) 2012-02-14 2013-02-14 Rotavirus subunit vaccines and methods of making and use thereof

Publications (1)

Publication Number Publication Date
HK1200326A1 true HK1200326A1 (en) 2015-08-07

Family

ID=47755047

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15100745.1A HK1200326A1 (en) 2012-02-14 2015-01-23 Rotavirus subunit vaccines and methods of making and use thereof

Country Status (22)

Country Link
US (1) US9446117B2 (pt)
EP (1) EP2814508B1 (pt)
JP (1) JP6149240B2 (pt)
KR (1) KR102087458B1 (pt)
CN (1) CN104203274B (pt)
AR (2) AR089995A1 (pt)
AU (1) AU2013221479B2 (pt)
BR (1) BR112014020025B1 (pt)
CA (1) CA2864106C (pt)
DK (1) DK2814508T5 (pt)
EA (1) EA034564B1 (pt)
ES (1) ES2632429T3 (pt)
HK (1) HK1200326A1 (pt)
HU (1) HUE033858T2 (pt)
LT (1) LT2814508T (pt)
MX (1) MX353786B (pt)
NZ (1) NZ628282A (pt)
PH (1) PH12014501795A1 (pt)
PL (1) PL2814508T3 (pt)
PT (1) PT2814508T (pt)
SI (1) SI2814508T1 (pt)
WO (1) WO2013123219A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10004797B2 (en) 2010-10-27 2018-06-26 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
RU2649132C1 (ru) * 2017-08-03 2018-03-29 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства Способ получения активного начала вакцины против ротавирусной инфекции белка FliCVP6VP8
CN108864260A (zh) * 2018-07-17 2018-11-23 昆明学院 非结构蛋白nsp4、重组杆状病毒液及制备、粘膜佐剂
CN109306007B (zh) * 2018-09-26 2021-10-08 华中农业大学 抗猪繁殖与呼吸综合征病毒nsp4蛋白基因工程抗体及应用
US20220160864A1 (en) * 2020-10-05 2022-05-26 Boehringer Ingelheim Animal Health USA Inc. Fusion protein comprising circoviridae capsid protein, and chimeric virus-like particles composed thereof
CN114875047A (zh) * 2022-05-27 2022-08-09 江苏三仪生物工程有限公司 一种优化的猪轮状病毒外衣壳蛋白vp4的重组表达及应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
CA1247080A (en) 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
DE3584341D1 (de) 1984-08-24 1991-11-14 Upjohn Co Rekombinante dna-verbindungen und expression von polypeptiden wie tpa.
US5186933A (en) 1986-12-30 1993-02-16 Baylor College Of Medicine Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
US5147639A (en) * 1990-06-19 1992-09-15 Ambico, Inc. Type-c rotavirus cultures and uses therefor
US5298244A (en) 1990-10-25 1994-03-29 University Of Saskatchewan Assembled viral particles and their use in a vaccine to rotaviral disease
BE1006085A3 (fr) 1992-07-31 1994-05-10 Univ Bruxelles Vecteur de clonage.
WO1996034109A1 (en) 1995-04-25 1996-10-31 Vical Incorporated Single-vial formulations of dna/lipid complexes
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
AU6387196A (en) * 1995-06-14 1997-01-15 Baylor College Of Medicine Rotavirus enterotoxin nsp4 and methods of using same
US5846946A (en) 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
FR2751226B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
FR2751228B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
FR2751224B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
FR2751229B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751225B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique aviaire
WO1998016247A1 (en) 1996-10-11 1998-04-23 The Regents Of The University Of California Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
ATE275423T1 (de) 1997-06-30 2004-09-15 Aventis Pharma Sa Verabreichung der nukleinsäure in den quergestreiften muskel
WO1999058652A2 (en) 1998-05-07 1999-11-18 Gx Biosystems A/S Cytotoxin-based biological containment
FR2778858B1 (fr) 1998-05-20 2000-06-16 Oreal Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique
US6716431B1 (en) 1998-05-29 2004-04-06 Wyeth Holdings Corporation Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
US6187319B1 (en) 1998-06-01 2001-02-13 University Of Massachusetts Cross-protective rotavirus vaccine
US6589529B1 (en) * 1998-10-30 2003-07-08 Children's Hospital Medical Center Rotavirus subunit vaccine
FR2801607B1 (fr) 1999-11-26 2001-12-28 Merial Sas Pneumovirus du canard et vaccins correspondants
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
US6867353B2 (en) 2000-02-12 2005-03-15 Exploregen Inc. Production method of recombinant rotavirus structural proteins and vaccine composition
EP1349571A4 (en) * 2000-11-03 2005-02-16 Baylor College Medicine ROTAVIRUS ENTEROTOXIN NSP4 AND METHOD FOR ITS USE
WO2004056390A1 (en) 2002-12-19 2004-07-08 Akzo Nobel Patent Department Trivalent vaccine with maternal antibody transfer via the milk
DE602004013331T2 (de) 2003-07-24 2009-07-16 Merial Ltd. Vakzin-formulierungen mit einer öl-in-wasser-emulsion
WO2006007555A2 (en) * 2004-07-01 2006-01-19 Children's Medical Center Corporation ¨ Rotavirus antigens
US7691368B2 (en) * 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
BRPI0504441A (pt) 2005-10-20 2007-06-26 Fundacao Oswaldo Cruz vetores de expressão plasmidial contendo regiões especìficas para a expressão de proteìnas ou epìtopos recombinantes de rotavìrus e astrovìrus, processo de produção dos insumos para geração de imunobiológicos para diagnóstico
KR20080100384A (ko) * 2006-03-03 2008-11-17 메리얼 리미티드 마이코플라즈마 하이오뉴모니아에 백신
US9169296B2 (en) 2008-05-29 2015-10-27 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Expression and assembly of human group C rotavirus-like particles and uses thereof
EP2310511B1 (fr) 2008-07-18 2015-01-14 Sanofi Pasteur Vecteur auto replicatif depourvu de gene de resistance a un antibiotique
MX2012002814A (es) 2009-09-10 2012-08-17 Merial Ltd Nuevas formulaciones de vacuna que comprenden adyuvantes que contienen saponina.

Also Published As

Publication number Publication date
SI2814508T1 (sl) 2017-10-30
AU2013221479B2 (en) 2017-06-08
JP2015508776A (ja) 2015-03-23
DK2814508T3 (da) 2017-05-22
LT2814508T (lt) 2017-06-26
EP2814508A1 (en) 2014-12-24
AR126891A2 (es) 2023-11-29
CN104203274B (zh) 2017-09-08
PH12014501795B1 (en) 2014-11-17
BR112014020025B1 (pt) 2022-09-27
PT2814508T (pt) 2017-07-19
CN104203274A (zh) 2014-12-10
JP6149240B2 (ja) 2017-06-21
KR102087458B1 (ko) 2020-03-10
BR112014020025A8 (pt) 2022-07-12
US9446117B2 (en) 2016-09-20
EP2814508B1 (en) 2017-04-12
HUE033858T2 (en) 2018-01-29
ES2632429T3 (es) 2017-09-13
MX353786B (es) 2018-01-29
EA034564B1 (ru) 2020-02-20
CA2864106A1 (en) 2013-08-22
BR112014020025A2 (pt) 2017-07-04
EA201400914A1 (ru) 2014-12-30
AR089995A1 (es) 2014-10-01
AU2013221479A1 (en) 2014-08-28
DK2814508T5 (da) 2017-06-12
PH12014501795A1 (en) 2014-11-17
US20130209507A1 (en) 2013-08-15
KR20140123592A (ko) 2014-10-22
MX2014009722A (es) 2015-02-20
WO2013123219A1 (en) 2013-08-22
NZ628282A (en) 2016-08-26
PL2814508T3 (pl) 2017-09-29
CA2864106C (en) 2017-10-17

Similar Documents

Publication Publication Date Title
HK1258014A1 (zh) 含前列腺酰胺的眼內植入物及其使用方法
HK1216322A1 (zh) 組糖基轉移酶及其應用
GB2535360B (en) Methods of preparing polyhemiaminals and polyhexahydrotriazines
ZA201408236B (en) Anti-ly6e antibodies and immunoconjugates and methods of use
ZA201501858B (en) Anti-mcam antibodies and associated methods of use
EP2912178A4 (en) SUPER AMPLIFIER AND METHOD FOR USE THEREOF
EP2967683A4 (en) ADAPTABLE INTERVERTEBRAL IMPLANT AND METHODS OF USE
EP2838444A4 (en) EXPANDABLE OCCLUSION DEVICES AND METHODS OF USE
EP2800528A4 (en) DEABLABLE OCCLUSION DEVICES AND USE METHOD THEREFOR
IL238227A0 (en) Antibodies against c16orf54 and uses thereof
EP2844903A4 (en) TUBES AND METHOD FOR THE PRODUCTION AND USE THEREOF
ZA201404675B (en) Anti-lrp5 antibodies and methods of use
EP2806811A4 (en) VERTEBRAL CONSTRUCTION
EP2938632A4 (en) ANTI-GRANULYSIN ANTIBODIES AND METHODS OF USE
HK1200326A1 (en) Rotavirus subunit vaccines and methods of making and use thereof
EP2897639A4 (en) IMPROVED VACCINE COMPOSITIONS AND METHODS OF USE
EP2852397A4 (en) HUWENTOXIN IV VARIANTS AND METHODS OF USE
HK1209432A1 (en) Anti-jagged antibodies and methods of use
EP2897680A4 (en) INFLATION DEVICES AND APPLICATION METHOD
IL234906A0 (en) Colchicine compositions, methods of production and methods of using them
HK1209325A1 (en) Attenuated swine influenza vaccines and methods of making and use thereof
EP2852413A4 (en) XENOANTIGEN WITH VACCINES AGAINST CANCER AND MANUFACTURING PROCESS THEREFOR
HK1258694A1 (zh) 減毒溶血曼海姆氏菌疫苗及其製造和用途
EP2895474A4 (en) LEGIBLE MODULATORS AND METHOD OF USE THEREFOR
ZA201408128B (en) Etract of greyia radlkoferi and use thereof